Back to results
US 2017/0000849 A1Published application
Cd300a receptors as virus entry cofactors
AssigneesInstitut National De La Sante Et De La Recherche Medicale (Inserm), Centre National de la Recherche Scientifique (CNRS), Universite Paris Diderot—Paris 7
InventorsAli AMARA, Xavier CARNEC, Laurent MEERTENS
Life of this patent
Estimating the term…
Abstract
The present invention concerns an inhibitor of an interaction between CD300a and an aminophospholipid for use in preventing or treating a virus infection by inhibition of the interaction between CD300a and viral aminophospholipid.
Claims12
A method for preventing or treating a viral infection comprising administering to an individual in need hereof a therapeutically effective amount of an inhibitor of an interaction between CD300a and viral aminophospholipid.
(canceled)
Dependencies are inferred from the claim text.